期刊文献+

复方地龙胶囊对短暂性脑缺血发作相关生化的影响 被引量:2

The effect of treating transient ischemic attack with Fufang Dilong capsules
下载PDF
导出
摘要 目的:观察复方地龙胶裳对短暂性脑缺血发作相关生化的影响.方法:符合条件病例80例,予复方地龙胶囊2粒/次,3次/日,疗程均为30天.评定指标包括治疗前后相关生化指标,包括血小板计数、总胆固醇(Tc)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、纤维蛋白原(FIB),血沉(ESR).结果:治疗前后相关化验指标,包括血小板计数、TC、LDL-C,FIB、ESR均有明显改善.结论:复方地龙胶囊疗效明显,可用于治疗及预防短暂性生脑缺血发作. Objective: To observe the effect of Fufang Dilong capsules on treating transient ischemic with biochemical attack. Methods: Coincidence conditions 80 cases were treated with Fufang Dilong capsules 2 grains/time, 3 times/d, and 30 days for one course. Evaluation indicators includes biochemical parameters before and after treatment, includes platelet count, TC, TG, LDL-C, FIB, ESR. Results: Laboratory indicators before and after treatment, include platelet count, TC, LDL-C, FIB, ESR has significantly improved. Conclusion: Fufang Dilong capsules has a good effect on treating and preventing transient ischemic attack.
作者 李宝柱 杨敏
出处 《中医临床研究》 2010年第22期25-25,共1页 Clinical Journal Of Chinese Medicine
关键词 复方地龙胶囊 短暂性脑缺血发作 疗效观察 Fufang Dilong capsules Transient ischemic attack Effective observation
  • 相关文献

参考文献4

二级参考文献17

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 2史玉泉.实用神经病学[M]第2版[M].上海:上海科学技术出版社,1994.645.
  • 3华杨.实用颈动脉与颅脑血管超声诊断学[M].北京:科学出版社,2002,8.58-66.
  • 4Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview, Ann Periodontol. 2001, 6(1): 1-8.
  • 5Chambless LE, Folsom AR, Clegg LX et al. Carotid wall thickness is predictive of incident clinical stroke, the Arteriosclerosis Risk in Communities (ARIC) Study. Am J Epidenmiol, 2000, 151(5): 478-487.
  • 6O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative ResearchGroup. N Engl J Med, 1999, 340(1): 14-22.
  • 7Mazoyer E, Drouet L, Soria C et al. Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude. Thromb Res, 1999, 95(4): 163-176.
  • 8Tataru MC, Schulte H, von Eckardstein A et al. Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Coron Artery Dis, 2001, 12(3): 157-165.
  • 9Schmidt H, Schmidt R, Niederkorn K et al. Horner S, Becsagh P, Reinhart B, Schumacher M, Weinrauch V, Kostner GM. Betafibrinogen gene polymorphism (C148-->T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vase Biol, 1998, 18(3): 487-492.
  • 10Smith EB, Thompson WD. Fibrin as a factor in atherogenesis. Thromb Res, 1994, 73(1): 1-19.

共引文献211

同被引文献10

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部